Semaglutide is a medication often used to manage blood sugar levels in people with type 2 diabetes and to assist in weight loss
Of the 92,807 adverse events reported for semaglutide drugs, about 440 people experienced AKI
The mean age of participants was 53 years, mean HbA 1c was 66 mmol/mol (8.2%), mean duration of diabetes was 5.6 years, mean FPG was 9.1 mmol/l and mean body weight was 79.5 kg
Cravings feel less intense, it becomes easier to recognize when youre comfortably full, and the urge to snack constantly starts to fade
According to co-author Karsten Eastman, a research associate in the university's Department of Chemistry and CEO and co-founder of Sethera Therapeutics, these structures are more stable, remain active longer, and can better interact with their biological targets